# Lineage Cell Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/lineage-cell-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 28 | | Claims under review | 1 | | Evidence records | 4 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-22T04:46:36.198947+00:00 | | Last reviewed | 2026-10-22T04:46:36.198947+00:00 | ## Identity - Legal name: Lineage Cell Therapeutics, Inc. - Display name: Lineage Cell Therapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-22T20:40:05.487778+00:00 | | Completeness | 0.409 | | Record Quality | 0.82 | | Directors | 8 | | Committees | 3 | | Governance events | 7 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Angus C. Russell: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2014-01-01. Committees: Audit Committee (member); Compensation Committee (chair). claim_id=alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:leadership_role:8 - Anula Jayasuriya: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2021-01-01. Committees: Nominating & Corporate Governance Committee (member). claim_id=alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:leadership_role:9 - Brian M. Culley: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2018-01-01. claim_id=alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:leadership_role:10 - Deborah Andrews: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2014-01-01. Committees: Audit Committee (chair); Compensation Committee (member). claim_id=alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:leadership_role:11 - Dipti Amin: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2021-01-01. Committees: Compensation Committee (member). claim_id=alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:leadership_role:12 - George A. Samuel III: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2021-01-01. claim_id=alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:leadership_role:13 - Neal C. Bradsher: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2009-01-01. Committees: Nominating & Corporate Governance Committee (chair). claim_id=alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:leadership_role:14 - Michael H. Mulroy: Chairman of the Board. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:leadership_role:7 ## Committees - Audit Committee (audit). Chair: Deborah Andrews. Members: Deborah Andrews (chair, current); Angus C. Russell (member, current). committee_id=alpha:committee:lineage-cell-therapeutics-inc:audit-committee - Compensation Committee (compensation). Chair: Angus C. Russell. Members: Angus C. Russell (chair, current); Deborah Andrews (member, current); Dipti Amin (member, current). committee_id=alpha:committee:lineage-cell-therapeutics-inc:compensation-committee - Nominating & Corporate Governance Committee (nominating_governance). Chair: Neal C. Bradsher. Members: Neal C. Bradsher (chair, current); Anula Jayasuriya (member, current). committee_id=alpha:committee:lineage-cell-therapeutics-inc:nominating-corporate-governance-committee ## Executive leadership - Brian M. Culley: Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:leadership_role:15 - George A. Samuel III: General Counsel and Corporate Secretary [GC]. Status: unknown. claim_id=alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:leadership_role:16 - Jill A. Howe: Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:leadership_role:17 ## Governance events - DIRECTOR_APPOINTED: Anula Jayasuriya seat on Lineage Cell Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-22T04:46:36.198947+00:00. event_id=alpha:event:transition:r4ujq721amvl - DIRECTOR_APPOINTED: Dipti Amin seat on Lineage Cell Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-22T04:46:36.198947+00:00. event_id=alpha:event:transition:rf9usld4nr6b - DIRECTOR_APPOINTED: George A. Samuel III seat on Lineage Cell Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-22T04:46:36.198947+00:00. event_id=alpha:event:transition:qug7xe15hkzxy - DIRECTOR_APPOINTED: Brian M. Culley seat on Lineage Cell Therapeutics, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-22T04:46:36.198947+00:00. event_id=alpha:event:transition:1c5u61psjiyzf - DIRECTOR_APPOINTED: Angus C. Russell seat on Lineage Cell Therapeutics, Inc., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-22T04:46:36.198947+00:00. event_id=alpha:event:transition:fpgai8szedza - DIRECTOR_APPOINTED: Deborah Andrews seat on Lineage Cell Therapeutics, Inc., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-22T04:46:36.198947+00:00. event_id=alpha:event:transition:1vhsp9wepxcfa - DIRECTOR_APPOINTED: Neal C. Bradsher seat on Lineage Cell Therapeutics, Inc., effective 2009-01-01. Effective: 2009-01-01. Detected: 2026-10-22T04:46:36.198947+00:00. event_id=alpha:event:transition:1ehy7llqfi01b ## Scoped resources - `alpha://company/lineage-cell-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/lineage-cell-therapeutics-inc?format=record - `alpha://company/lineage-cell-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/lineage-cell-therapeutics-inc?format=record§ion=identity - `alpha://company/lineage-cell-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/lineage-cell-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/lineage-cell-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/lineage-cell-therapeutics-inc?format=record§ion=board - `alpha://company/lineage-cell-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/lineage-cell-therapeutics-inc?format=record§ion=committees - `alpha://company/lineage-cell-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/lineage-cell-therapeutics-inc?format=record§ion=leadership - `alpha://company/lineage-cell-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/lineage-cell-therapeutics-inc?format=record§ion=ownership - `alpha://company/lineage-cell-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/lineage-cell-therapeutics-inc?format=record§ion=financials - `alpha://company/lineage-cell-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/lineage-cell-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/lineage-cell-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/lineage-cell-therapeutics-inc?format=record§ion=compensation - `alpha://company/lineage-cell-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/lineage-cell-therapeutics-inc?format=record§ion=governance - `alpha://company/lineage-cell-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/lineage-cell-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/lineage-cell-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/lineage-cell-therapeutics-inc?format=record§ion=audit - `alpha://company/lineage-cell-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/lineage-cell-therapeutics-inc?format=record§ion=legal - `alpha://company/lineage-cell-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/lineage-cell-therapeutics-inc?format=record§ion=risk - `alpha://company/lineage-cell-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/lineage-cell-therapeutics-inc?format=record§ion=cyber - `alpha://company/lineage-cell-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/lineage-cell-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/lineage-cell-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/lineage-cell-therapeutics-inc?format=record§ion=agents - `alpha://company/lineage-cell-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/lineage-cell-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/lineage-cell-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/lineage-cell-therapeutics-inc?format=record§ion=events - `alpha://company/lineage-cell-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/lineage-cell-therapeutics-inc?format=record§ion=relationships - `alpha://company/lineage-cell-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/lineage-cell-therapeutics-inc?format=record§ion=assessments - `alpha://company/lineage-cell-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/lineage-cell-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Audit Committee","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:deborah-andrews-lctx","name":"Deborah Andrews"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Audit Committee","category":"audit","role":"member","person":{"alpha_id":"alpha:person:angus-c-russell-lctx","name":"Angus C. Russell"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Compensation Committee","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:angus-c-russell-lctx","name":"Angus C. Russell"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Compensation Committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:deborah-andrews-lctx","name":"Deborah Andrews"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Compensation Committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:dipti-amin-lctx","name":"Dipti Amin"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:committee_appointment:26: `{"kind":"committee_appointment","original_name":"Nominating & Corporate Governance Committee","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:neal-c-bradsher-lctx","name":"Neal C. Bradsher"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:committee_appointment:27: `{"kind":"committee_appointment","original_name":"Nominating & Corporate Governance Committee","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:anula-jayasuriya-lctx","name":"Anula Jayasuriya"},"source_id":"governance_people_committees"}` ## Leadership - Michael H. Mulroy: Chairman of the Board. Claim: alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:leadership_role:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:32707d23e7044f4d5f2dc0ab3d6a200cdd9cb0593d0603bc2080445a9a6a0c5d. - Angus C. Russell: Director. Claim: alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:leadership_role:8. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:eb6a60fe49ed4158ac7cbe0b0eb1bee13bb3fda14249f8454301914e7efb7406. - Anula Jayasuriya: Director. Claim: alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:leadership_role:9. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:eb6a60fe49ed4158ac7cbe0b0eb1bee13bb3fda14249f8454301914e7efb7406. - Brian M. Culley: Director. Claim: alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:leadership_role:10. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:eb6a60fe49ed4158ac7cbe0b0eb1bee13bb3fda14249f8454301914e7efb7406. - Deborah Andrews: Director. Claim: alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:leadership_role:11. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:eb6a60fe49ed4158ac7cbe0b0eb1bee13bb3fda14249f8454301914e7efb7406. - Dipti Amin: Director. Claim: alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:leadership_role:12. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:eb6a60fe49ed4158ac7cbe0b0eb1bee13bb3fda14249f8454301914e7efb7406. - George A. Samuel III: Director. Claim: alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:leadership_role:13. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:eb6a60fe49ed4158ac7cbe0b0eb1bee13bb3fda14249f8454301914e7efb7406. - Neal C. Bradsher: Director. Claim: alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:leadership_role:14. Valid from: 2009-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:eb6a60fe49ed4158ac7cbe0b0eb1bee13bb3fda14249f8454301914e7efb7406. - Brian M. Culley: Chief Executive Officer. Claim: alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:32707d23e7044f4d5f2dc0ab3d6a200cdd9cb0593d0603bc2080445a9a6a0c5d. - George A. Samuel III: General Counsel and Corporate Secretary. Claim: alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:32707d23e7044f4d5f2dc0ab3d6a200cdd9cb0593d0603bc2080445a9a6a0c5d. - Jill A. Howe: Chief Financial Officer. Claim: alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:32707d23e7044f4d5f2dc0ab3d6a200cdd9cb0593d0603bc2080445a9a6a0c5d. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit Committee: Chair Deborah Andrews; Members Deborah Andrews (Chair); Angus C. Russell. Claim: alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:committee_record:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c557c0a0050da741e5034c24dbcbfa6cd019173d24b53efab360748a4601779e. - Compensation Committee: Chair Angus C. Russell; Members Angus C. Russell (Chair); Deborah Andrews; Dipti Amin. Claim: alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:committee_record:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c557c0a0050da741e5034c24dbcbfa6cd019173d24b53efab360748a4601779e. - Nominating & Corporate Governance Committee: Chair Neal C. Bradsher; Members Neal C. Bradsher (Chair); Anula Jayasuriya. Claim: alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:committee_record:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c557c0a0050da741e5034c24dbcbfa6cd019173d24b53efab360748a4601779e. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Lineage Cell Therapeutics, Inc.. Claim: alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:246e21284327ef5d48e181792dc94380b5532fd8131600a960ef737c97463fc1. ## Entity Status - Public listing published. Claim: alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:246e21284327ef5d48e181792dc94380b5532fd8131600a960ef737c97463fc1. ## Published Fact - US. Claim: alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:246e21284327ef5d48e181792dc94380b5532fd8131600a960ef737c97463fc1. - Healthcare. Claim: alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:246e21284327ef5d48e181792dc94380b5532fd8131600a960ef737c97463fc1. - Biotechnology. Claim: alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:published_fact:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:246e21284327ef5d48e181792dc94380b5532fd8131600a960ef737c97463fc1. ## Committee Appointment - Deborah Andrews: chair, Audit Committee. Claim: alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c557c0a0050da741e5034c24dbcbfa6cd019173d24b53efab360748a4601779e. - Angus C. Russell: member, Audit Committee. Claim: alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c557c0a0050da741e5034c24dbcbfa6cd019173d24b53efab360748a4601779e. - Angus C. Russell: chair, Compensation Committee. Claim: alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c557c0a0050da741e5034c24dbcbfa6cd019173d24b53efab360748a4601779e. - Deborah Andrews: member, Compensation Committee. Claim: alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c557c0a0050da741e5034c24dbcbfa6cd019173d24b53efab360748a4601779e. - Dipti Amin: member, Compensation Committee. Claim: alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c557c0a0050da741e5034c24dbcbfa6cd019173d24b53efab360748a4601779e. - Neal C. Bradsher: chair, Nominating & Corporate Governance Committee. Claim: alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c557c0a0050da741e5034c24dbcbfa6cd019173d24b53efab360748a4601779e. - Anula Jayasuriya: member, Nominating & Corporate Governance Committee. Claim: alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:committee_appointment:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c557c0a0050da741e5034c24dbcbfa6cd019173d24b53efab360748a4601779e. ## Security Listing - LCTX (NYSE). Claim: alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:security_listing:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:246e21284327ef5d48e181792dc94380b5532fd8131600a960ef737c97463fc1. - LCTX (NYSE AMERICAN). Claim: alpha:claim:company:564c5cf5-a5fb-49a6-bdce-0982655c7ab6:security_listing:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:246e21284327ef5d48e181792dc94380b5532fd8131600a960ef737c97463fc1. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:246e21284327ef5d48e181792dc94380b5532fd8131600a960ef737c97463fc1: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/lineage-cell-therapeutics-inc). - alpha:projection-evidence:document:32707d23e7044f4d5f2dc0ab3d6a200cdd9cb0593d0603bc2080445a9a6a0c5d: [SEC DEF 14A 0001193125-26-191556](https://www.sec.gov/Archives/edgar/data/876343/000119312526191556/lctx-20260429.htm). - alpha:projection-evidence:document:eb6a60fe49ed4158ac7cbe0b0eb1bee13bb3fda14249f8454301914e7efb7406: [DEF 14A lctx-20260429.htm](https://www.sec.gov/Archives/edgar/data/876343/000119312526191556/lctx-20260429.htm). - alpha:projection-evidence:c557c0a0050da741e5034c24dbcbfa6cd019173d24b53efab360748a4601779e: [Audit Committee](https://www.sec.gov/Archives/edgar/data/876343/000119312526191556/lctx-20260429.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/lineage-cell-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/lineage-cell-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/lineage-cell-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/lineage-cell-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/lineage-cell-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-22T20:40:05.151913+00:00; recorded 2026-10-22T20:40:05.151913+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.